Arjo saw the highest growth of 0.39% in patent filings in June and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 2.99%. GlobalData’s DataBook provides a comprehensive analysis of Arjo‘s patent filings and grants. Buy the databook here.
Arjo has been focused on protecting inventions in Australia(AU) with three publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 43% of filings. The Australia(AU), European Patent Office(EPO), United States(US), and Denmark(DK) patent Office are among the top ten patent offices where Arjo is filings its patents. Among the top granted patent authorities, Arjo has 33% of its grants in United States(US) and 33% in Canada(CA).
Stryker and Medtronic could be the strongest competitors for Arjo
In terms of grant share, Arjo stands first among its competitors followed by Stryker and Medtronic.
Patents related to healthtech and connected patient lead Arjo's portfolio
Arjo has the highest number of patents in healthtech followed by, connected patient and wearable tech. For healthtech, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Hospital supplies related patents lead Arjo portfolio followed by other remote patient monitoring, and compression therapy
Arjo has highest number of patents in hospital supplies followed by other remote patient monitoring, compression therapy, tires and wheels, and hospital beds. For hospital supplies, nearly 30% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Arjo's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.